- idUS
- Listar por autor
Listar por autor "Lee, Jong Seok"
Mostrando ítems 1-1 de 1
-
Artículo
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Paz Ares, Luis; Ramalingam, Suresh S.; Ciuleanu, Tudor Eliade; Lee, Jong Seok; Urban, Laszlo; Bernabé-Caro, Reyes; Reck, Martin (ELSEVIER SCIENCE INC, 2022)Introduction: In CheckMate 227, nivolumab plus ipilimu mab prolonged overall survival (OS) versus chemotherapy in patients ...